The androgen receptor in prostate cancer

Pathology Research and Practice

Volumn 192, Issue 7, 1996, Pages 752-760

  Trapman, J ^a   Brinkmann, A O ^a  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

Androgen receptor; Function; Mutation; Prostate cancer; Structure

Indexed keywords

ANDROGEN RECEPTOR; CELL NUCLEUS RECEPTOR;

ANDROGEN INSENSITIVITY SYNDROME; CANCER STAGING; GENE CONTROL; GENE EXPRESSION; GENE MUTATION; HORMONAL THERAPY; HUMAN; MALE; METASTASIS; MOTOR NEURON DISEASE; PROSTATE CANCER; REVIEW; SOMATIC MUTATION;

EID: 0029743193     PISSN: 03440338     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0344-0338(96)80097-5     Document Type: Article

References (79)

1. Adler AJ, Scheller A, Hoffman Y, Robins DM (1991) Multiple components of a. complex androgen dependent enhancer. Mol Endocrinol 5: 1587-1596
2. Alarid ET, Rubin JS, Young P, Chedid M, Ron D, Aaronson SA, Cunha GR (1994) Keratinocyte growth factor functions in epithelial induction during seminal vesicle development. Proc Natl Acad Sci USA 91: 1074-1078
3. Beato M, Herrlich P, Schuetz G (1995) Steroid hormone receptors: many actors in search of a plot. Cell 83: 851 -857
4. Bentvelsen FM, Brinkmann AO, Van der Schoot P, Van der Linden JETM, Van der Kwast ThH, Boersma WJ, Schroder FH, Nijman JM (1995) Developmental pattern and regulation by androgens of androgen receptor expression in the urogenital tract of the rat. Mol Cell Endocrinol 113: 245-253
5. Boring CC, Squires TS, Tong T, Montgomery S (1994) Cancer statistics 1994. CA Cancer J Clin 44: 7-26
6. Brinkmann AO, Trapman J (1992) Androgen receptor mutants that affect normal growth and development. Cancer Surveys 14: 95-111
7. Chodak GW, Kranc DM, Puy LA, Takeda H, Johnson K, Chang C (1992) Nuclear localization of androgen receptor in heterogeneous samples of normal, hyperplastic and neoplastic human prostate. J Urol 147: 798-803
8. Chung LWK, Gleave ME, Hsieh JT, Hong S-J, Zhau HE (1991) Reciprocal mesenchymal-epithelial interaction affecting prostate tumor growth and hormonal responsiveness. Cancer Survey 11.-91-121
9. Claessens F, Celis L, Peeters B, Heyns W, Verhoeven G, Rombauts W (1989) Functional characterization of an androgen response element in the first itron of the C3(I) gene of prostatic binding protein. Biochem Biophys Res Commun 164: 833-840
10. Cleutjens CBJM, Van Eekelen CCEM, Van der Korput JAGM, Brinkmann AO, Trapman J (1996) Two androgen response regions cooperate in steroid hormone regulation of the prostate specific antigen promoter. J Biol Chem (In Press)
11. Coffey DS (1993) Prostate cancer: An overview of an increasing dilemma. Cancer 71: 880-886
12. Cooke PS, Young P, Cunha GR (1991) Androgen receptor expression in developing male reproductive organs. Endocrinol 128: 286-2873
13. Crawford ED, Eisenberger MA, McLeod DG, Spaulding JT, Benson R, Dorr FA, Blumenstein BA, Davis MA, Goodman PJ (1989) A controlled trial of leuprolide with and without flutamide in prostatic carcinoma. N Engl J Med 321: 419-424
14. Culig Z, Hobisch A, Cronauer MV, Cato ACB, Hittmair A, Radmayr C, Eberle J, Bartsch G, Kiocker H (1993) Mutant androgen receptor detected in an advanced-stage prostatic carcinoma is activated by adrenal androgens and progesterone. Mol Endocrinol 7: 1541-1550
15. Culig Z, Hobisch A, Cronauer MV, Radmayr C, Trapman J, Hittmair A, Bartsch G, Kiocker H (1994) Androgen receptor activation in prostate tumor cell lines by insulin-like growth factor-1, keratinocyte growth factor, and epidermal growth factor. Cancer Res 54: 5474-5478
16. Cunha GR, Chung LWK (1981) Stromal-epithelial interactions: I. Induction of prostatic phenotype in urothelium of testicular feminized mice. J Steroid Biochem 14: 1317-1321
17. Cunha GR, Donjacour AA, Cooke PS, Mee S, Bigsby, RM, Higgins, SJ, Sugimura (1987) The endocrinology and developmental biology of the prostate. Endocr Rev 8: 338-362
18. Cunha GR (1994) Role of mesenchymal epithelial interactions in normal and abnormal development of the mammary gland and prostate. Cancer 74: 1030-1044
19. Denis L (1994) Role of maximal androgen blockade in advanced prostate cancer. The Prostate Suppl 5: 17-22
20. Donjacour AA, Cunha GR (1993) Assessment of prostatic protein secretion in tissue recombinants made of urogenital sinus mesenchyme and urothelium from normal or androgen insensitive mice. Endocrinol 232: 2342-2350
21. Evans RM (1988) The steroid and thyroid hormone receptor superfamily. Science 240: 889-895
22. Fawell SE, Lees JA, White R, Parker MG (1990) Characterization and colocalization of steroid binding and dimerization activities in the mouse estrogen receptor. Cell 60: 953-962
23. Gaddipati JP, McLeod DG, Heidenberg HB, Sesterhenn IA, Finger MJ, Moul JW, Srivastava S (1994) Frequent detection of codon 877 mutation in the androgen receptor gene in advanced prostate cancers. Cancer Res 54: 2861-2864
24. Gleave M, Hsieh J-T, Gao C, Von Eschenbach AC, Chung LWK (1991) Acceleration of human prostate cancer growth in vivo by factors produced by prostate and bone fibrobtasts. Cancer Res 52: 3753-3761
25. Hobisch A, Culig Z, Radmayer C, Bartsch G, Klocker H, Hittmair A (1995) Distant metastases from prostatic carcinoma express androgen receptor protein. Cancer Res 55: 3068-3072
26. Husmann DA, McPhaul MJ, Wilson JD (1991) Androgen receptor expression in the developing rat prostate is not altered by castration, flutamide, or suppression of the adrenal axis. Endocrinol 128: 1902-1906
27. Ikonen T, Palvimo JJ, Kallio PJ, Reinikainen P, Janne OA (1994) Stimulation of androgen-regulated transactivation by modulators of protein phosphorylation. Endocrinol 235: 1359-1399
28. Jenster G, Van der Korput HAGM, Van Vroonhoven C, Van der Kwast ThH, Trapman J, Brinkmann AO (1991) Domains of the human androgen receptor involved in steroid binding, transcriptional activation and nuclear binding. Mol Endocrinol 5: 1390-1404
29. Jenster G, Trapman J, Brinkmann AO (1993) Nuclear import of the human androgen receptor. Biochem J 293: 761-768
30. Jenster G, De Ruiter PE, Van der Korput JAGM, Kuiper GGJM, Trapman J, Brinkmann AO (1994) Differential change in androgen receptor protein pattern upon hormone treatment and by mutation of putative phosphorylation sites. Biochemistry 33: 14064-14072
31. Jenster G, Van der Korput JAGM, Trapman J, Brinkmann AO (1995) Identification of two transcription activation units in the Nterminal domain of the human androgen receptor. J Biol Chem 269: 7341-7346
32. Kallio PJ, Palvimo JJ, Mehto M, Janne OA (1994) Analysis of androgen receptor-DNA interactions with receptor proteins produced in insect cells. J Biol Chem 269: 11514-11522
33. Kasper S, Rennie PS, Bruchovsky N, Sheppard PC, Cheng H, Lin L, Shiu RP, Snoek R, Matusik RJ (1994) Cooperative binding of androgen receptors to two DNA sequences is required for androgen induction of the probasin gene. J Biol Chem 269: 31763-31769
34. Kazemi-Esfarjani P, Trifiro MA, Pinsky L (1995) Evidence for a repressive function of the long polyglutamme tract in the human androgen receptor: possible pathogenetic relevance for the (CAG)n-expanded neuronopathies. Hum Mol Genet 4: 523-527
35. Kraus WL, McInerney EM, Katzenellenbogen BS (1995) Liganddependent, transcriptionally productive association of the amino- and carboxyl-terminal regions of a steroid hormone nuclear receptor. Proc Natl Acad Sci USA 92: 12314-12318
36. Kwast van der ThH, Schalken J, Ruizeveld de Winter JA, Van Vroonhoven CCJ, Mulder E, Trapman J (1991) Androgen receptors in endocrine-therapy resistant human prostate cancer. Int J Cancer 48: 189-193
37. Langley E, Zhou Z-X, Wilson EM (1995) Evidence for an antiparallel orientation of the ligand-activated human androgen receptor dimer. J Biol Chem 270: 29983-29990
38. La Spada AR, Wilson EM, Lubahn DB, Harding AE, Fischbeck KH (1991) Androgen receptor mutations in X-linked spinal and bulbar muscular atrophy. Nature 352: 77-79
39. Lieberman B, Bona BJ, Edwards DP, Nordeen SK (1993) The constitution of a progesterone response element. Mol Endrocrinol 7: 515-527
40. Lobaccaro JM, Lumbros S, Belon C, Galtier-Dereure F, Bringer J, Lesimple T, Namer M, Cutuli BF, Pujol H, Sultan C (1993) Androgen receptor gene mutation in male breast cancer. Hum Mol Genet 2: 1799-1802
41. Luisi BF, Xu WX, Otwinowski Z, Freedman LP, Yamamoto KR, Sigler PB (1991) Cristallographic analysis of the interaction of the glucocorticoid receptor with DNA. Nature 352: 497-505
42. Lund SD, Gallagher PM, Wang B, Porter SC, Ganschow RE (1991) Androgen responsiveness of the murine beta-glucuronidase gene is associated with nuclease hypersensitivity, protein binding, and haplotype-specific sequence diversity within intron 9. Mol Cell Biol 11: 5426-5434
43. McPhaul JJ, Marcelli M, Zoppi S, Griffin JE, Wilson JD (1993) Genetic basis of endocrine disease: 4. The spectrum of mutations in the androgen receptor gene that causes androgen resistance. J Clin Endocrinol Metab 76: 17-23
44. Murtha P, Tindall DJ, Young CYF (1993) Androgen induction of a human prostate specific kallikrein, hKLK-2: characterization of an androgen response element in the 5′ promoter region of the gene. Biochemistry 2: 6459-6464
45. Newmark JR, Hardy O, Tonb DC, Carter BS, Epstein JI, Isaacs WB, Brown TR, Barrack ER (1992) Androgen receptor gene mutations in human prostate cancer. Proc Natl Acad Sci USA 89: 6319-6323
46. Nordeen SK, Suh BJ, Kuhnel B, Hutchison CA (1990) Structural determinants of a glucocorticoid response element. Mol Endocrinol 4: 1866-1873
47. Patterson MN, Hughes IA, Gottlieb B, Pinsky L (1994) The androgen receptor gene mutations data base. Nucl Acids Res 22: 3560-3562
48. Pertschuk LP, Schaeffer H, Feldman JG, Macchia RJ, Kim Y-D, Eisenberg K, Braithwaite LV, Axiotis CA, Prins G, Greene GL (1995) Immunostaining for prostate cancer androgen receptor in paraffin identifies a subset of men with a poor prognosis. Lab Invest 73: 302-305
49. Peterziel H, Culig Z, Stober J, Hobisch A, Radmayr C, Bartsch G, Klocker H, Cato ACB (1995) Mutant androgen receptors in prostate tumors distinguish between amino acid sequence requirements for transactivation and ligand binding. Int J Cancer 63: 544-550
50. Pinsky L, Trifiro M, Kaufman M, Beitel LK, Mhatre A, KazemiEsfarjani P, Sabbaghian N, Lumbroso R, Alvarado C, Vasiliou M (1992) Androgen resistance due to mutation of the androgen receptor. Clin Invest Med 15: 456-472
51. Quigley CA, De Bellis A, Marschke KB, El-Awady MK, Wilson EM, French FS (1995) Androgen receptor defects: historical, clinical, and molecular perspectives. Endocrine Rev 16: 271-321
52. Rennie PS, Bruchovsky N, Leco KJ, Sheppard PC, MsQueen SA, Cheng H, Snoek R, Hamel A, Bock ME, MacDonald BS, Matusik RJ (1993) Characterization of two cis acting DNA elements involved in the androgen regulation of the probasin gene. Mol Endocrinol 7: 23-36
53. Riegman PHJ, Vlietstra RJ, Van der Korput JAGM, Romijn JC, Traprnan J (1991) Identification and androgen regulated expression of two major human glandular kallikrein-I (hGK-1) mRNA species. Mol Cell Endocrinol 76: 181-190
54. Riegman PHJ, Vlietstra RJ, Van der Korput JAGM, Brinkmann AO, Trapman J (1991) The promoter of the prostate specific antigen gene contains a functional androgen response element. Mol Endocrinol 5: 1921-1930
55. Ris-Stalpers C, Verleun-Mooijman MCT, Trapman J, Brinkmann AO (1993) Threonine on position 868 in the human androgen receptor is essential for androgen binding specificity and functional activity Biochem Biophys Res Commun 296: 173-180
56. Roche PJ, Hoare SA, Parker MG (1992) A consensus DNA-binding site for the androgen receptor. Mol Endocrinol 6: 2229-2235
57. Ruiter PE de, Teuwen R, Trapman J, Dijkema R, Brinkmann AO (1995) Synergism between androgens and protein kinase C on androgen-regulated gene expression. Mol Cell Endocrinol 110: R1-R6
58. Ruizeveld de Winter JA, Trapman J, Vermey M, Mulder E, Zegers ND, Van der Kwast ThH (1991) Androgen receptor expression in human tissues: An immunohistochemical study. J Histochem Cytochem 39: 927-936
59. Ruizeveld de Winter JA, Janssen PJA, Sleddens HMFB, VerleunMooijman MCT, Trapman J, Brinkmann AO, Santerse AB, Schroeder FH, Van der Kwast ThH (1994) Androgen receptor status in localized and locally progressive hormone-refractory human prostate cancer. Amer J Pathol 144: 735-746
60. Sadi MV, Walsh PC, Barrack ER (1991) Immunohistochemical study of androgen receptors in metastatic prostate cancer. Comparison of receptor content and response to hormonal therapy. Cancer 67: 3057-3064
61. Sadi MV, Barrack ER (1993) Image analysis of androgen receptor immunostaining in metastatic prostate cancer. Heterogeneity as a predictor of response to hormonal therapy. Cancer 71: 2574-2580
62. Sartor O, Cooper M, Weinberger M, Headlee D, Thibault A, Tompkins A, Steinberg S, Figg WD, Linehan WM, Myers CE (1994) Surprising activity of flutamide withdrawal, when combined with aminoglutethimide, in treatment of "hormone-refractory" prostate cancer. J Natl Cancer Inst 86: 222-227
63. Scher HI, Kelly WK (1993) Flutamide withdrawal syndrome: its impact on clinical trials in hormone-refractory prostate cancer. J Clin Oncol 11: 1566 -1572
64. Schuurman AL, Bolt J, Voorhorst MM, Blankenstein RA, Mulder E (1988) Regulation of growth and epidermal growth factor receptor levels of LNCaP prostate tumor cells by different steroids. Int J Cancer 42: 917-922
65. Shannon JM, Cunha GR (1983) Autoradiographic localization of androgen binding in the developing mouse prostate. Prostate 4: 367-373
66. Simental JA, Sar M, Lane MV, French FS, Wilson EM (1991) Transcriptional activation and nuclear targeting signals of the human androgen receptor. J Biol Chem 266: 510-518
67. Suzuki H, Sato N, Watabe Y, Masai M, Seino S, Shimazaki (1993) Androgen receptor gene mutations in human prostate cancer. J Steroid Biochem Mol Biol 46: 759-765
68. Tan J, Marschke KB, Ho K-C, Perry ST, Wilson EM, French FS (1992) Response elements of the androgen regulated C3 gene. J Biol Chem 267: 4456-4464
69. Taplin M-E, Bubley GJ, Shuster TD, Frantz ME, Spooner AE, Ogata GK, Keer HN, Balk SP (1995) Mutation of the androgen receptor gene in metastatic androgen-independent prostate cancer. N Engl J Med 332: 1393-1398
70. Thigpen AE, Davis DL, Milatovich A, Mendoaca BB, ImperatoMcGinley J, Griffin JE, Francke U, Wilson JD, Russell DW (1992) Molecular genetics of steroid 5alpha-reductase 2 deficiency. J Clin Invest 90: 799-809
71. Tilley WD, Lim-Tio SS, Horsfall DJ, Aspinall JO, Marshall VR, Skinner JM (1994) Detection of discrete androgen receptor epitopes in prostate cancer by immunostaining: measurement by color video image analysis. Cancer Res 54: 4096-4102
72. Truss M, Beato M (1993) Steroid hormone receptors: interaction with deoxyribonucleic acid and transcription factors. Endocrine Rev 14: 459-479
73. Veldscholte J, Ris-Stalpers C, Kuiper GGJM, Jenster G, Berrevoets C, Claassen E, Van Rooij HCJ, Trapman J, Brinkmann AO, Mulder E (1990) A mutation in the ligand binding domain of the androgen receptor of human LNCaP cells affects steroid binding characteristics and response to anti-androgens. Biochem Biophys Res Commun 173: 534-540
74. Visakorpi T, Hyytinen E, Koivisto P, Tanner M, Keinanen R, Palmberg C, Tammela T, Isola J, Kallioniemi OP (1995) In vivo amplification of the androgen receptor gene and progression of human prostate cancer. Nature Genet 9: 401-406
75. Wong C-I, Zhou Z-X, Sar M, Wilson EM (1993) Steroid requirement for androgen receptor dimerization and DNA binding. J Biol Chem 268: 19004-19012
76. Wooster R, Mangion J, Eeles R, Smith S, Dowsett M, Averill D, Barrett-Lee P, Easton DF, Ponder BA, Stratton MR (1992) A germline mutation in the androgen receptor gene in two brothers with breast cancer and Reifenstein syndrome. Nature Genet 2: 132-143
77. Yan G, Fukabori Y, Nikolaropoulos S, Wang F, McKeehan WL (1992) Heparin binding keratinocyte growth factor is a candidate stromal to epithelial cell andromedin. Mol Endocrinol 6: 2123-2128
78. Zhou Z-X, Sar M, Simental JA, Lane MV, Wilson EM (1994) A ligand dependent bipartite nuclear targeting signal in the human androgen receptor. J Biol Chem 269: 13115-13123
79. Zhou Z-X, Lane MV, Kemppainen JA, French FS, Wilson EM (1995) Specificity of ligand-dependent androgen receptor stabilization: receptor domain interactions influence ligand dissociation and receptor stability. Mol Endocrinol 9: 208-218